APTC- hændelser 35/ 6. 950 patienter (0, 50%) for lumiracoxib mod 27/ 6. 968 patienter (0, 39%) for NSAID med et RF på 1, 22 [95% KI 0, 74- 2, 02] p=0, 4343.
35/ 6950 patients (0.50%) for lumiracoxib versus 27/ 6968 patients (0.39%) for NSAIDs, with a HR of 1.22 [95% CI 0.74-2.02] p=0.4343.